Home › Companies › SUMMIT THERAPEUTICS INC. › 2023-2024

SUMMIT THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and SUMMIT THERAPEUTICS INC.’s Form 8-K, filed June 17, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 12Reported items
  • 108Asset managers
  • 1,478Fund votes
  • June 14, 2024Main meeting date

Results at a glance

Meeting of June 14, 2024: 10 items on SUMMIT THERAPEUTICS INC.’s Form 8-K, filed June 17, 2024: 10 without a stated outcome.

Meeting of October 12, 2023: 1 item on SUMMIT THERAPEUTICS INC.’s Form 8-K, filed October 16, 2023: 1 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore SUMMIT THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by SUMMIT THERAPEUTICS INC.

These tallies are SUMMIT THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. SUMMIT THERAPEUTICS INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.

SUMMIT THERAPEUTICS INC. — official shareholder meeting results, meeting held June 14, 2024 (Form 8-K, filed June 17, 2024)
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Robert W. Duggan 620,632,521---- 362,13318,922,547 99.9%Not verified—
Elect Director: Mahkam Zanganeh 620,696,167---- 298,48718,922,547 99.9%Not verified—
Elect Director: Manmeet S. Soni 620,032,830---- 961,82418,922,547 99.8%Not verified—
Elect Director: Kenneth A. Clark 612,562,945---- 8,431,70918,922,547 99%Not verified—
Elect Director: Robert Booth 620,631,600---- 363,05418,922,547 99.9%Not verified—
Elect Director: Alessandra Cesano 613,253,170---- 7,741,48418,922,547 99%Not verified—
Elect Director: Yu Xia 620,368,580---- 626,07418,922,547 99.8%Not verified—
Elect Director: Mostafa Ronaghi 619,032,689---- 1,961,96518,922,547 99.6%Not verified—
Ratification of the appointment of PricewaterhouseCoopers LLP, United States 639,287,77639,750589,675 ---- 99.9%Not verified—
Approval, on a non-binding advisory basis, of the compensation of the named executive officers 604,242,48215,872,371879,801 --18,922,547 97%Not verified—

Source: SUMMIT THERAPEUTICS INC., Form 8-K, filed with the SEC on June 17, 2024 — read the filing on EDGAR.

SUMMIT THERAPEUTICS INC. — official shareholder meeting results, meeting held October 12, 2023 (Form 8-K, filed October 16, 2023)
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Set forth below is the number of votes cast for, against or withheld, as well as the number of abstentions and broker non-votes, as to the Proposal: 567,632,1977,904,039167,675 ---- 99%Not verified—

Source: SUMMIT THERAPEUTICS INC., Form 8-K, filed with the SEC on October 16, 2023 — read the filing on EDGAR.

How asset managers voted at the SUMMIT THERAPEUTICS INC. 2023-2024 meetings

Each item below shows how the 108 asset managers that disclosed a SUMMIT THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of SUMMIT THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Alessandra Cesano

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held June 14, 2024.

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 613,253,170WITHHELD: 7,741,484
Details: description as filed, official tally, votes by 41 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Alessandra Cesano

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Alessandra Cesano”): 613,253,170 for, 7,741,484 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 41 asset managers below reported 5,212,307 for, 4,288,410 withheld, 22,179 abstained.

FORWITHHOLD
FOR: 5,212,307ABSTAIN: 22,179WITHHOLD: 4,288,410
Largest asset managers voting on “ELECTION OF DIRECTORS: Alessandra Cesano” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,085,4590 068,451For
BlackRock00 01,563,023Withhold
Vanguard00 01,423,306Withhold
State Street2,5630 01,012,967Withhold
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable94,4100 042,038Mixed
ProShares125,9960 00For
Federated Hermes114,8340 00For
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial00 098,100Withhold
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya00 039,466Withhold
Pacific Life00 037,162Withhold
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust00 22,1790Abstain
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

2. Elect Director: Kenneth A. Clark

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held June 14, 2024.

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 612,562,945WITHHELD: 8,431,709
Details: description as filed, official tally, votes by 41 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Kenneth A. Clark

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kenneth A. Clark”): 612,562,945 for, 8,431,709 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 41 asset managers below reported 4,589,540 for, 4,911,177 withheld, 22,179 abstained.

FORWITHHOLD
FOR: 4,589,540ABSTAIN: 22,179WITHHOLD: 4,911,177
Largest asset managers voting on “ELECTION OF DIRECTORS: Kenneth A. Clark” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity00 03,153,910Withhold
BlackRock00 01,563,023Withhold
Vanguard1,423,3060 00For
State Street1,015,3600 0170For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable94,4100 042,038Mixed
ProShares125,9960 00For
Federated Hermes00 0114,834Withhold
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life00 037,162Withhold
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust00 22,1790Abstain
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

3. Elect Director: Mahkam Zanganeh

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held June 14, 2024.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 620,696,167WITHHELD: 298,487
Details: description as filed, official tally, votes by 41 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Mahkam Zanganeh

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mahkam Zanganeh”): 620,696,167 for, 298,487 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 41 asset managers below reported 9,522,856 for, 40 withheld.

FOR
FOR: 9,522,856WITHHOLD: 40
Largest asset managers voting on “ELECTION OF DIRECTORS: Mahkam Zanganeh” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,153,9100 00For
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,4900 040For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes114,8340 00For
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

4. Elect Director: Manmeet S. Soni

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held June 14, 2024.

Combines 2 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 620,032,830WITHHELD: 961,824
Details: description as filed, official tally, votes by 41 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Manmeet S. Soni

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Manmeet S. Soni”): 620,032,830 for, 961,824 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 41 asset managers below reported 9,375,244 for, 146,553 withheld, 1,099 abstained.

FOR
FOR: 9,375,244ABSTAIN: 1,099WITHHOLD: 146,553
Largest asset managers voting on “ELECTION OF DIRECTORS: Manmeet S. Soni” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,153,9100 00For
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,4900 040For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes00 0114,834Withhold
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI00 030,800Withhold
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

5. Elect Director: Mostafa Ronaghi

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held June 14, 2024.

Combines 2 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 619,032,689WITHHELD: 1,961,965
Details: description as filed, official tally, votes by 41 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Mostafa Ronaghi

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mostafa Ronaghi”): 619,032,689 for, 1,961,965 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 41 asset managers below reported 8,382,790 for, 1,140,106 withheld.

FOR
FOR: 8,382,790WITHHOLD: 1,140,106
Largest asset managers voting on “ELECTION OF DIRECTORS: Mostafa Ronaghi” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity2,013,8040 01,140,106Mixed
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,5300 00For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes114,8340 00For
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

6. Elect Director: Robert Booth

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held June 14, 2024.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 620,631,600WITHHELD: 363,054
Details: description as filed, official tally, votes by 41 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Robert Booth

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert Booth”): 620,631,600 for, 363,054 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 41 asset managers below reported 9,522,896 for.

FOR
FOR: 9,522,896
Largest asset managers voting on “ELECTION OF DIRECTORS: Robert Booth” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,153,9100 00For
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,5300 00For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes114,8340 00For
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

7. Elect Director: Robert W. Duggan

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held June 14, 2024.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 620,632,521WITHHELD: 362,133
Details: description as filed, official tally, votes by 41 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Robert W. Duggan

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert W. Duggan”): 620,632,521 for, 362,133 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 41 asset managers below reported 9,522,856 for, 40 withheld.

FOR
FOR: 9,522,856WITHHOLD: 40
Largest asset managers voting on “ELECTION OF DIRECTORS: Robert W. Duggan” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,153,9100 00For
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,4900 040For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes114,8340 00For
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

8. ELECTION OF DIRECTORS: Ujwala Mahatme

No official matchDIRECTOR ELECTIONS

Meeting held June 14, 2024.

Combines 2 wordings of this item as funds reported it.

87% of fund votes cast · no official result

FOR
Details: votes by 41 asset managers

The 41 asset managers below reported 8,267,786 for, 1,255,110 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 8,267,786WITHHOLD: 1,255,110
Largest asset managers voting on “ELECTION OF DIRECTORS: Ujwala Mahatme” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity2,013,8040 01,140,106Mixed
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,3600 0170For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes00 0114,834Withhold
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

9. Elect Director: Yu Xia

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Meeting held June 14, 2024.

Combines 3 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 620,368,580WITHHELD: 626,074
Details: description as filed, official tally, votes by 41 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Yu Xia

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Yu Xia”): 620,368,580 for, 626,074 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 41 asset managers below reported 9,408,022 for, 114,874 withheld.

FOR
FOR: 9,408,022WITHHOLD: 114,874
Largest asset managers voting on “ELECTION OF DIRECTORS: Yu Xia” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,153,9100 00For
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,4900 040For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes00 0114,834Withhold
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

10. To approve an amendment to the Summit Therapeutics Inc. 2020 Stock Incentive Plan to increase the number of shares of…

No official matchCOMPENSATION

Meeting held October 12, 2023.

Combines 4 wordings of this item as funds reported it.

5% of fund votes cast · no official result

AGAINST
Details: description as filed, votes by 33 asset managers

Description as filed by funds: To approve an amendment to the Summit Therapeutics Inc. 2020 Stock Incentive Plan to increase the number of shares of the Company's common stock issuable under the Plan by 70,000,000 shares.

The 33 asset managers below reported 164,237 for, 3,287,537 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 164,237AGAINST: 3,287,537
Largest asset managers voting on “To approve an amendment to the Summit Therapeutics Inc. 2020 Stock Incentive Plan to increase the number of sh” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock01,014,497 00Against
Vanguard0716,539 00Against
Fidelity0518,291 00Against
ALPS ETF Trust0420,576 00Against
Equitable0165,880 00Against
Lincoln Financial98,1000 00For
ETF Series Solutions065,808 00Against
Northern Trust51,4790 00For
ETFis Series Trust I050,714 00Against
Voya046,304 00Against
AIG/SunAmerica045,041 00Against
Brighthouse040,272 00Against
Pacific Life037,635 00Against
John Hancock034,154 00Against
Bridge Builder Trust020,304 00Against
Federated Hermes017,877 00Against
Charles Schwab015,739 00Against
ProShares015,567 00Against
Nationwide014,279 00Against
Principal012,084 00Against
Invesco011,452 00Against
State Street10,2580 00For
Calvert09,569 00Against
PENN SERIES FUNDS INC4,4000 00For
Morgan Stanley03,907 00Against

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

11. Approval, on a non-binding advisory basis, of the compensation of the named executive officers

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Meeting held June 14, 2024.

Combines 7 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 604,242,482AGAINST: 15,872,371
Details: description as filed, official tally, votes by 105 asset managers

Description as filed by funds: Approval, by a non-binding advisory vote, of the compensation of our named executive officers.

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Approval, on a non-binding advisory basis, of the compensation of the named executive officers”): 604,242,482 for, 15,872,371 against, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 41 asset managers voting on “Approval, by a non-binding advisory vote, of the compensation of our named executive officers.” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity03,153,910 00Against
BlackRock01,563,023 00Against
Vanguard01,423,306 00Against
State Street1,0971,014,433 00Against
Charles Schwab0800,404 00Against
First Trust0356,386 00Against
Equitable0136,448 00Against
ProShares0125,996 00Against
Federated Hermes0114,834 00Against
Direxion Shares ETF Trust0113,719 00Against
Lincoln Financial098,100 00Against
Principal Exchange-Traded Funds065,255 00Against
TIAA065,077 00Against
ETF Series Solutions060,426 00Against
John Hancock053,987 00Against
Northern Trust51,8410 00For
ALPS ETF Trust049,109 00Against
Voya039,466 00Against
Pacific Life037,162 00Against
AQR036,883 00Against
SEI030,800 00Against
ETFis Series Trust I027,122 00Against
Bridge Builder Trust022,179 00Against
DWS018,036 00Against
Principal014,497 00Against

Fund voting reports, all 41 managers: 55,598 for, 9,467,298 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 76 asset managers voting on “Approval, by a non-binding advisory vote, of the compensation of our named executive officers.” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street1,0972,268,098 00Against
BlackRock62,9992,047,522 00Against
GEODE CAPITAL MANAGEMENT, LLC02,003,519 00Against
Fidelity01,865,277 00Against
Charles Schwab0800,404 00Against
Northern Trust552,5771,565 00For
MELLON INVESTMENTS Corp0428,286 00Against
Wellington0266,881 00Against
UBS0168,172 00Against
SECTORAL ASSET MANAGEMENT INC165,0000 00For
BANK OF AMERICA NA0146,281 00Against
MARSHALL WACE, LLP0143,148 00Against
Vanguard0135,926 00Against
Federated Hermes0114,834 00Against
Rafferty Asset Management, LLC0113,719 00Against
AllianceBernstein094,410 00Against
HoyleCohen, LLC83,0470 00For
PRINCIPAL GLOBAL INVESTORS079,752 00Against
John Hancock077,123 00Against
Nuveen075,473 00Against
Invesco057,666 00Against
JPMorgan053,177 00Against
HighTower Advisors, LLC052,100 00Against
NEW YORK STATE COMMON RETIREMENT FUND048,325 00Against
Goldman Sachs043,219 00Against

Institutional-manager reports, all 76 managers: 958,574 for, 11,559,873 against, 19,142 abstained. Showing the 25 largest; see all in the interactive database.

12. Ratification of the appointment of PricewaterhouseCoopers LLP, United States

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Meeting held June 14, 2024.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 639,287,776AGAINST: 39,750
Details: description as filed, official tally, votes by 41 asset managers

Description as filed by funds: Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2024.

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Ratification of the appointment of PricewaterhouseCoopers LLP, United States”): 639,287,776 for, 39,750 against, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 41 asset managers below reported 9,522,896 for.

FOR
FOR: 9,522,896
Largest asset managers voting on “Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm” at SUMMIT THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,153,9100 00For
BlackRock1,563,0230 00For
Vanguard1,423,3060 00For
State Street1,015,5300 00For
Charles Schwab800,4040 00For
First Trust356,3860 00For
Equitable136,4480 00For
ProShares125,9960 00For
Federated Hermes114,8340 00For
Direxion Shares ETF Trust113,7190 00For
Lincoln Financial98,1000 00For
Principal Exchange-Traded Funds65,2550 00For
TIAA65,0770 00For
ETF Series Solutions60,4260 00For
John Hancock53,9870 00For
Northern Trust51,8410 00For
ALPS ETF Trust49,1090 00For
Voya39,4660 00For
Pacific Life37,1620 00For
AQR36,8830 00For
SEI30,8000 00For
ETFis Series Trust I27,1220 00For
Bridge Builder Trust22,1790 00For
DWS18,0360 00For
Principal14,4970 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

Largest SUMMIT THERAPEUTICS INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 701,974,596 shares outstanding at the time of that meeting.

Fund voting reports: top SUMMIT THERAPEUTICS INC. shareholders by shares voted on “Approval, by a non-binding advisory vote, of the compensation of our named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1Fidelity 0.45%
2BlackRock 0.22%
3Vanguard 0.20%
4State Street 0.14%
5Charles Schwab 0.11%
6First Trust 0.05%
7Equitable 0.02%
8ProShares 0.02%
9Federated Hermes 0.02%
10Direxion Shares ETF Trust 0.02%
Institutional-manager reports: top SUMMIT THERAPEUTICS INC. shareholders by shares voted on “Approval, by a non-binding advisory vote, of the compensation of our named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1State Street 0.32%
2BlackRock 0.30%
3GEODE CAPITAL MANAGEMENT, LLC 0.29%
4Fidelity 0.27%
5Charles Schwab 0.11%
6Northern Trust 0.08%
7MELLON INVESTMENTS Corp 0.06%
8Wellington 0.04%
9UBS 0.02%
10SECTORAL ASSET MANAGEMENT INC 0.02%

Reported SUMMIT THERAPEUTICS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

SUMMIT THERAPEUTICS INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
Robert W. Duggan 78.12% DEF14A
Mahkam Zanganeh 5.04% DEF14A
Vanguard Group 1.62% 13F
FMR (Fidelity) 1.27% 13F
State Street 1.16% 13F
BlackRock 1.05% 13F
Geode Capital 0.45% 13F
Morgan Stanley 0.27% 13F
Northern Trust 0.15% 13F
Charles Schwab 0.14% 13F

Percentages above are of 701,974,596 shares outstanding, as reported by SUMMIT THERAPEUTICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SUMMIT THERAPEUTICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At SUMMIT THERAPEUTICS INC.'s 2 shareholder meetings in the 2023-2024 proxy season (held October 12, 2023 and June 14, 2024), 108 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,478 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held June 14, 2024 — Approval, by a non-binding advisory vote, of the compensation of our named executive officers. — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: SUMMIT THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 17, 2024.

SUMMIT THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.